Our top resource picks

All resources

Filters
  • Clear filters
Resource Image
Article

Dapagliflozin: UK court reaffirms plausibility standard despite G 2/21

In Generics, Teva & Glenmark v AstraZeneca, the High Court restated how inventive step and sufficiency are assessed...
Resource Image
Article

Key considerations when patenting bispecific antibodies in Europe

Technology overview Bispecific monoclonal antibodies (BsAbs) are antibody constructs that create additional strategies in designing therapeutic avenues due...
Resource Image
Article

Webinar: European design reforms from 1 May 2025

Reform of designs in the EU is now in full swing, with the first phase taking full effect...
Resource Image
Article

Key considerations when patenting chimeric antigen receptor technologies in Europe

We explore the therapeutic indications addressed by Chimeric Antigen Receptors (CARs) and CAR T-cell therapy and consider patent...
Resource Image
Article

Patenting AI innovations in healthcare: navigating European patent law

Artificial intelligence (AI) is revolutionising the healthcare industry by enhancing our ability to accurately diagnose diseases and predict...
Resource Image
Article

EUIPO rolls out phase 1 of changes to the European design system

From 1 May 2025, the European Union Intellectual Property Office (EUIPO) is implementing the first phase of its...
Resource Image
Article

Protecting your IP on Amazon: A practical guide for sellers

This white paper provides practical guidance for businesses facing IP challenges on Amazon. Whether you are a brand...
Resource Image
Article

Key considerations when patenting biologics in Europe

Biologics are fuelling a technological revolution in medicine. The increasing prominence of biologics in modern medicine has led...
Resource Image
Legal Update

Patent Law & Practice at a Glance – April 2025

Read our April 2025 patent law and practice updates, including updates from the UK, the European Patent Office...